Medical/Pharmaceuticals

TELUS Mental Health Index: Singapore's workforce faces growing mental health crisis, threatening productivity and physical health

New research reveals sharp declines in mental health scores reversing two years of modest but steady improvement SINGAPORE, Nov. 21, 2024 /PRNewswire/ -- Today, TELUS Health released its TELUS Mental Health Index (the "Index") with reports examining the mental health of employed people inSingapo...

2024-11-22 00:01 1158

TELUS Mental Health Index: 40 per cent of workers in New Zealand have high mental health risk as productivity losses mount

Workers diagnosed with anxiety lose more than 68 working days of productivity per year, underscoring the economic impact ofNew Zealand's declining mental health scores AUCKLAND, New Zealand, Nov. 22, 2024 /PRNewswire/ - Today, TELUS Health released itsTELUS Mental Health Index ("the Index") with...

2024-11-22 00:00 1023

SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

Launch of new application enables global access to highly recognized solid tumor profiling assay BOSTON and ROLLE, Switzerland, Nov. 21, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, announced the global launch of MSK-IM...

2024-11-21 18:30 1249

3Shape A/S and Medit Corp. Reach Settlement in Patent Infringement Lawsuit

COPENHAGEN, Denmark, Nov. 21, 2024 /PRNewswire/ -- 3Shape A/S, a global innovator in digital dentistry with its market-leading intraoral (IOS) scanners, and Medit Corp, a leading provider of dental 3D scanners, today announced they have settled U.S. patent infringement litigation. Both companies...

2024-11-21 18:18 1202

BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series

New seven-part series explores disparities in care, funding and innovation impacting half the world's population LONDON, Nov. 21, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc  (NYSE:CLVT), a leading global provider of transformative intelligence, has launched its new special series,'...

2024-11-21 16:00 1215

APRIL Group Supports National Health Development in Riau Province, Indonesia

SINGAPORE, Nov. 21, 2024 /PRNewswire/ -- Leading pulp, paper and board producer APRIL Group has further strengthened its commitment to improving public health by donating essential medical equipment to a local health facility in Riau province inSumatra, Indonesia, close to where the company's man...

2024-11-21 13:36 1512

/C O R R E C T I O N -- Sky Labs/

In the news release, Sky Labs' Blood Pressure Monitoring Device Recognized for High Accuracy by the International Society of Hypertension, issued24-Oct-2024 by Sky Labs over PR Newswire, we are advised by the company that there are updates to the content. The complete, corrected release follows: ...

2024-11-21 08:00 1096

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

– Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including$420 million in near-term milestone payments and opt-in right for solid tumors – – Companies to jointly develop and commercialize ziftomenib; 50/50 profit share in the U.S.; Kura to lead...

2024-11-21 06:00 1656

GBI Biomanufacturing Expands Capabilities with Automated Aseptic Fill-Finish for Drug Products

PLANTATION, Fla., Nov. 21, 2024 /PRNewswire/ -- GBI Biomanufacturing (GBI), one of the world's longest serving contract development and manufacturing organizations (CDMO), is pleased to announce the expansion of its Drug Product (DP)services, to include automated sterile fill and finish capabilit...

2024-11-21 01:00 1179

SD Biosensor and the NCCD Discuss Cooperation Measures to Eradicate Infectious Diseases

* A team of officials from the National Center for Communicable Diseases, Mongolia (NCCD), had a tour around the Cheongju and Jeungpyeong Factories of SD Biosensor, aSouth Korea's global in-vitro diagnostics company, during their visit to Korea. * SD Biosensor introduced total diagnostic plat...

2024-11-20 12:44 1197

Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies

SINGAPORE, Nov. 20, 2024 /PRNewswire/ -- Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, andEdith Cowan University Australia (ECU) today announced a new strategic partnership that aims to enhance clinical ultrasound training for healthcare professio...

2024-11-20 09:00 7915

Samsung Biologics signs manufacturing deal with European pharmaceutical company

* The company will provide manufacturing services through 2031 in deals worth overUSD 668 million * Samsung Biologics' cumulative contract value for 2024 surpasses USD 4 billion with latest deals INCHEON, South Korea, Nov. 20, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global ...

2024-11-20 07:23 1304

Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson's Research Through Development of Next Generation Biomarker Assays

FREMONT, Calif., Nov. 19, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce a strategic collaboration with The Michael J. Fox Foundation for Parkinson's Research (MJFF) to accelerate biomarker disco...

2024-11-19 22:12 1514

Say Hello to 3.0: Datarithm Releases Latest Version of Inventory Management Solution

SYRACUSE, N.Y., Nov. 19, 2024 /PRNewswire/ -- In a landscape marked by intense competition, rising costs, and stringent regulatory requirements, independent pharmacies face an array of challenges that threaten their viability and success. Today, Datarithm® is proud to announce a solution to these...

2024-11-19 22:00 1074

2024 Access to Medicine Index finds that pharma companies are missing opportunities to reach more patients in low- and middle-income countries

AMSTERDAM, Nov. 19, 2024 /PRNewswire/ -- The 2024 Access to Medicine Index finds that pharmaceutical companies are not fully leveraging thei...

2024-11-19 21:00 401

Brii Bio Delivers First Head-to-Head Comparison of siRNA (Elebsiran) and PEG-IFNα Combination versus PEG-IFNα Alone at AASLD's The Liver Meeting® 2024, Demonstrating Higher Loss of HBV Surface Antigen by Combining with siRNA

48-week end-of-treatment data from the ongoing Phase 2 ENSURE study clearly demonstrated the added benefits of elebsiran towards achieving a higher functional cure rate in combination with PEG-IFNα Data from multiple combination studies sponsored by the Company and its partner continue to suppor...

2024-11-19 19:30 1692

Digital Medicine Society Launches Resources to Navigate Global Digital Health Regulatory Pathways

Resources will speed the expansion of digital health products worldwide, improving global patient access  BOSTON, Nov. 19, 2024 /PRNewswire/ -- Today, the Digital Medicine Society (DiMe) unveiled a suite of resources to guide industry in evaluating international regulatory pathways. These resourc...

2024-11-19 19:00 1465

SiPH Collaborates with IBM to Enhance Pathology Information System with Computational Advances and AI to Support Patients in Thailand and ASEAN

BANGKOK, Nov. 19, 2024 /PRNewswire/ -- Siriraj Piyamaharajkarun Hospital (SiPH), operating under Faculty of Medicine Siriraj Hospital, today announced a successful transformation of its Pathology Information System (PIS) using advanced computational technologies and artificial intelligence. In c...

2024-11-19 17:07 1497

GHIT Fund Awarded Open Philanthropy Grant to Expand Funding Sources for Global Health R&D

TOKYO, Nov. 19, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund is pleased to announce that Open Philanthropy, a grantmaking organization based inSan Francisco, California, has awarded funding for efforts to cultivate new partnerships and secure resources from the private...

2024-11-19 09:00 1264

Everest Medicines Announces NEFECON® Has Received Full Approval from South Korea's Ministry of Food and Drug Safety (MFDS) for the Treatment of Primary IgA Nephropathy

SHANGHAI, Nov. 19, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that NEFECON® has received full appro...

2024-11-19 07:40 1626
1 ... 45678910 ... 398